Oklo advances AI-nuclear plans but losses and dilution weigh
Groves test reactor achieves first criticality with DOE approval Oklo won DOE approval for its Groves test reactor and achieved first criticality, a key technical milestone that shows its reactor design can work and supports its licensing path.
This is a new operational milestone that validates Oklo's technology and boosts investor confidence.
First revenue and $3B cash, plus $200M federal AI-nuclear program Oklo reported its first revenue of $1.2 million and holds $3 billion in cash, while joining a $200 million federal AI-nuclear program, strengthening its financial position and AI ties.
First revenue and a large cash balance are new financial positives that improve the company's outlook.
Widening losses, non-binding backlog, and $1B dilution Q2 losses widened to $48.5 million and H1 net loss hit $81.6 million; about 93% of its 14–18 GW backlog is non-binding, commercial revenue isn't expected before 2028, and a $1 billion at-the-market offering dilutes shareholders.
These are new negative financial details that highlight ongoing risks and shareholder dilution.
House passes Ratepayer Protection Act; competition and volatility persist The House passed the Ratepayer Protection Act, which could affect nuclear incentives, while Oklo faces competition from NextEra and GE Vernova and remains volatile due to short interest and AI-boom dependence.
This captures new regulatory and competitive dynamics that create both opportunities and risks.